These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6987948)

  • 1. [Comparative activity of depot sulfanilamides in experimental infection in mice caused by K1. pneumoniae].
    Padeĭskaia EN; Kutchak SN; Polukhina LM
    Antibiotiki; 1980 Mar; 25(3):193-8. PubMed ID: 6987948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental meningoencephalitis in mice caused by Klebsiella pneumoniae as a chemotherapeutic model].
    Padeĭskaia EN; Kutchak SN
    Antibiotiki; 1980 Feb; 25(2):135-40. PubMed ID: 6986844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity of di-N-hydroxyquinoxaline and depot-sulfanilamide derivatives in experimental NAG infection].
    Avtsyn AP; Pershin GN; Trager RS; Shakhlamov VA; Padeĭskaia EN
    Biull Eksp Biol Med; 1982 May; 93(5):76-8. PubMed ID: 7093514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and producing QnrA1.
    Rodríguez-Martínez JM; Pichardo C; García I; Pachón-Ibañez ME; Docobo-Pérez F; Pascual A; Pachón J; Martínez-Martínez L
    Clin Microbiol Infect; 2008 Jul; 14(7):691-7. PubMed ID: 18558942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of aspoxicillin on experimental pneumonia with Klebsiella pneumoniae in mice.
    Yamaguchi T; Ishii N; Tani K; Matsushita T; Matsumoto K
    Drugs Exp Clin Res; 1989; 15(6-7):291-6. PubMed ID: 2686954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Klebsiella pneumoniae infection in immunosuppressed mice treated with gentamicin (author's transl)].
    Fauchère JL; Berche P; Véron M; Kreis H; Crosnier J
    Ann Microbiol (Paris); 1978; 129(4):433-46. PubMed ID: 358887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
    Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
    Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of therapeutic efficacy of ureidopenicillins in comparison to sisomicin and cephalotin in experimental infections of rabbits.
    Dzierzanowska D; Klosinska E; Roszkowski W; Patzer J; Jeljaszewicz J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Sep; 250(3):312-21. PubMed ID: 6458186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory effect of thalidomide alone or in combination with augmentin in Klebsiella pneumoniae B5055 induced acute lung infection in BALB/c mice.
    Kumar V; Chhibber S
    Eur J Pharmacol; 2008 Sep; 592(1-3):146-50. PubMed ID: 18662682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin.
    Schiffelers RM; Storm G; ten Kate MT; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 2001 Feb; 45(2):464-70. PubMed ID: 11158742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of antibacterial in vitro activity of moxifloxacin and its effects on pulmonary clearance of Klebsiella pneumoniae in an animal experimental model.
    Drago L; De Vecchi E; Nicola L; Gismondo MR
    Arzneimittelforschung; 2005; 55(8):473-7. PubMed ID: 16149716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.
    Padilla E; Alonso D; Doménech-Sánchez A; Gomez C; Pérez JL; Albertí S; Borrell N
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2258-60. PubMed ID: 16723600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of rhIL-2 in inhalant form on experimental respiratory tract infection with Klebsiella pneumoniae in mice.
    Tang Y; Zhu JB; Cheng DS; Zhang XS; Zhou B; Shen HY
    Yao Xue Xue Bao; 2005 Jan; 40(1):17-21. PubMed ID: 15881320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of the action of some antibiotics in combination with the new sulfanilamide compound sulfapyridazine during the acute course of experimental staphylococcal infection].
    Buniatova IM; Golosova TV; Anikina TP
    Antibiotiki; 1966 May; 11(5):430-7. PubMed ID: 5184685
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of Klebsiella pneumoniae virulence determinants using an intranasal infection model.
    Lawlor MS; Hsu J; Rick PD; Miller VL
    Mol Microbiol; 2005 Nov; 58(4):1054-73. PubMed ID: 16262790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the chemotherapeutic action of sodium salts of sulfanilamides of prolonged and short action].
    Padeĭskaia EN; Polukhina LM; Pershin GN
    Farmakol Toksikol; 1966; 29(5):600-5. PubMed ID: 4870019
    [No Abstract]   [Full Text] [Related]  

  • 17. [Enhanced nonspecific anti-infective resistance to Klebsiella pneumoniae in mice immunostimulated with preparations P-84 and P-85].
    Toshkov A; Dimov V
    Acta Microbiol Bulg; 1985; 17():58-64. PubMed ID: 3914829
    [No Abstract]   [Full Text] [Related]  

  • 18. [An experimental study of phthazin--a sulfanilamide preparation for the treatment of intestinal infections].
    Padeĭskaia EN; Polukhina LM; Pershin GN; Belozerova KA
    Farmakol Toksikol; 1967; 30(1):76-82. PubMed ID: 5594365
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumonia.
    Fonseca-Aten M; Salvatore CM; Mejías A; Ríos AM; Chávez-Bueno S; Katz K; Gómez AM; McCracken GH; Hardy RD
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4128-36. PubMed ID: 16189089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation.
    Welling MM; Hiemstra PS; van den Barselaar MT; Paulusma-Annema A; Nibbering PH; Pauwels EK; Calame W
    J Clin Invest; 1998 Oct; 102(8):1583-90. PubMed ID: 9788972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.